|
31 |
Real-world clinical effectiveness and safety of vedolizumab and anti-tumor necrosis factor alpha treatment in ulcerative colitis and Crohn’s disease patients: a German retrospective chart review Enthalten in BMC gastroenterology Bd. 20, 8.7.2020, Nr. 1, date:12.2020: 1-15
|
|